Sector & Market
Gland Pharma Schedules ADIA One-on-One Investor Meeting
FII Activity
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
17th Nov 2026
- The document is an intimation of a scheduled one-on-one meeting between Gland Pharma Limited and an institutional investor.
- The event is a One-on-One Meeting with Abu Dhabi Investment Authority (ADIA).
- The meeting is scheduled for November 20, 2026. A specific time and time zone were not disclosed in the announcement.
- The stated purpose of the event is for an Analyst/Institutional Investor Meeting, as per the regulatory requirement.
- The disclosure does not specify if the meeting is scheduled before or after an earnings announcement.
- Management participants and their designations for the meeting were not provided in this intimation.
- The announcement does not indicate that any presentation, earnings deck, transcript, or recording will be made available.
- The document does not contain a specific compliance statement indicating that no unpublished price sensitive information (UPSI) will be shared.
Additional Notes Section
- This is a standalone regulatory filing and does not list any attachments such as invites, investor decks, or compliance letters.
- No financial data, guidance references, or presentation summaries were disclosed in this announcement.
- The intimation includes a disclaimer that the schedule is subject to change due to exigencies on the part of the Investor, Analyst, or the Company.